DoD Melanoma, Idea Award | W81XWH 20 MRP IA

Opportunity Information: Apply for W81XWH 20 MRP IA

The DoD Melanoma, Idea Award (FY20 MRP Idea Award) is a Department of Defense research funding opportunity aimed at sparking genuinely new directions in melanoma research. It is designed for projects that are innovative and untested, with an emphasis on high-risk ideas that could lead to high-reward outcomes if they succeed. The core intent is to move the field forward by encouraging concepts, theories, paradigms, and methods that are not simply extensions of what is already being done, but instead open up fresh lines of investigation. This matters in a military context because improving melanoma knowledge, patient care, and treatment options within the Military Health System can directly benefit active duty Service members, Veterans, other military beneficiaries, and also translate to broader public health impact.

A central requirement of the program is that the application proposes a well-formulated and testable novel hypothesis, supported by strong scientific reasoning and a solid study design. In other words, the award is not just for speculative brainstorming; it expects a clear scientific question and an approach that can realistically generate interpretable results. At the same time, the award explicitly avoids funding work that represents a logical continuation of an established research project. The program is trying to prevent applicants from repackaging ongoing research as "new" and instead wants ideas that would not typically be funded through more conservative mechanisms.

Innovation is the defining feature. Competitive proposals are expected to introduce a new paradigm, challenge an existing one, or reframe a stubborn problem from a distinctly new perspective. The announcement makes it clear what does not count as innovation: incremental advances, the next obvious step in a known line of work, or simply moving an approach from one cancer type to melanoma without a compelling and creative rationale. In practice, this means applicants need to show why their concept is meaningfully different from standard melanoma research trajectories and why taking the risk is justified by the potential payoff in knowledge or clinical relevance.

From an administrative standpoint, this opportunity was offered by the Department of Defense, Department of the Army, through USAMRAA, under Funding Opportunity Number W81XWH-20-MRP-IA. It falls under the Science and Technology and other Research and Development activity category and is associated with CFDA 12.420. The opportunity is listed as discretionary and supports funding through either grants or cooperative agreements, which typically indicates that awards may range from standard grant-like support to more involved agency participation depending on the mechanism used. Eligibility is described as unrestricted, meaning it is broadly open to many entity types, subject to any additional eligibility clarifications in the full announcement. The posting date was April 21, 2020, with an original closing date of September 24, 2020, and the program anticipated making about 9 awards. The listed award ceiling is shown as 0 in the provided record, which usually signals that applicants must consult the full funding announcement for the actual maximum award amount or that the ceiling is not captured in the summary field.

Overall, the DoD Melanoma, Idea Award is best understood as a catalyst for bold melanoma research concepts: it rewards originality, requires a testable hypothesis and rigorous design, and is intentionally structured to avoid funding projects that merely continue existing work. The program is geared toward creating new research avenues that could ultimately improve melanoma outcomes in military and civilian populations alike.

• The Department of Defense, Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Melanoma, Idea Award" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
• This funding opportunity was created on Apr 21, 2020.
• Applicants must submit their applications by Sep 24, 2020. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 9 candidate(s).
• Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.

Apply for W81XWH 20 MRP IA

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: